CD73+CD8+ T cells define a subset with anti-tumor potential in DLBCL patients

CD73+CD8+ T cells define a subset with anti-tumor potential in DLBCL patients

IntroductionCD73, a recently discovered immune checkpoint, catalyzes the conversion of AMP to adenosine, thereby suppressing anti-tumor immune responses.CD8+ T cells play a critical role in the immune response against cancer, yet their functionality can be modulated by various factors within the tum...

Full description

Saved in:

Bibliographic Details
Main Authors:	Lingyu Zhang, Rui Cheng, Zongbing Fan, Yunxiao Liu, Jie Huang, Jiabing Peng
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2025-05-01
Series:	Frontiers in Medicine
Subjects:	CD8+ T cells CD73 DLBCL cytotoxicity anti-tumor potential immunotherapy
Online Access:	https://www.frontiersin.org/articles/10.3389/fmed.2025.1526772/full
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

The CD39/CD73/Adenosine and NAD/CD38/CD203a/CD73 Axis in Cutaneous T-Cell Lymphomas
by: Liyun Lin, et al.
Published: (2025-02-01)

Assessment of CD4<sup>+</sup> cells subpopulations with the expressing CD39 and CD73 ectonucleotidases in children with psoriasis
by: D. G. Kuptsova, et al.
Published: (2022-07-01)

Research progress of CD39-CD73-adenosine pathway in immune regulation of hepatocellular carcinoma
by: Lin SUN, et al.
Published: (2024-12-01)

Targeting the CD39/CD73 pathway: New insights into cardiac fibrosis and inflammation in female cardiac surgery patients
by: Eitezaz Mahmood, et al.
Published: (2025-06-01)

Value of CD5 and CD79 in Evaluation of GIT Lymphoma
by: Huda Mohammed Abdulwahid, et al.
Published: (2025-04-01)

Altered CD73-Adenosine Signaling Linked to Infection in Patients undergoing hemodialysis
by: Xiang F, et al.
Published: (2025-01-01)

Metabolic reprogramming nanomedicine potentiates colon cancer sonodynamic immunotherapy by inhibiting the CD39/CD73/ADO pathway
by: Yuanyuan Zhang, et al.
Published: (2025-05-01)

Efficacy and pharmacodynamic effect of anti-CD73 and anti-PD-L1 monoclonal antibodies in combination with cytotoxic therapy: observations from mouse tumor models
by: Brajesh P. Kaistha, et al.
Published: (2024-12-01)

CD161+CD127+CD8+ T cell subsets can predict the efficacy of anti-PD-1 immunotherapy in non-small cell lung cancer with diabetes mellitus
by: Jingjing Qu, et al.
Published: (2024-12-01)

Apoptotic Vesicles Attenuate Acute Lung Injury via CD73-Mediated Inhibition of Platelet Activation and NETosis
by: Tan L, et al.
Published: (2025-01-01)

Dual CD47 and PD‐L1 blockade elicits anti‐tumor immunity by intratumoral CD8+ T cells
by: Susan N Christo, et al.
Published: (2024-01-01)

CD73: agent development potential and its application in diabetes and atherosclerosis
by: Dan Liu, et al.
Published: (2024-12-01)

Systematic exploration of the molecular characteristics of CD8+ T cells to predict the response to immunotherapy and the prognosis of patients with colon adenocarcinoma
by: Xin Shen, et al.
Published: (2024-12-01)

Targeting tumor metabolism to augment CD8+ T cell anti-tumor immunity
by: Huan Liu, et al.
Published: (2025-05-01)

Toxoplasma gondii ROP18 induces maternal–fetal dysfunction by downregulating CD73 expression on decidual macrophages
by: Jingjing Guo, et al.
Published: (2025-02-01)

CYTOTOXIC ACTIVITY OF DENDRITIC CELLS AGAINST ACTIVATED CD4+ AND CD8+T-LYMPHOCYTES IN THE CULTURE IN VITRO
by: T. V. Tyrinova, et al.
Published: (2012-05-01)

Research progress of CD73-adenosine signaling regulating hepatocellular carcinoma through tumor microenvironment
by: Liang Shan, et al.
Published: (2025-05-01)

CD73-expressing endometrial regenerative cell-derived exosomes mitigate acute cardiac allograft rejection through regulating adenosine metabolism in mice
by: Chenglu Sun, et al.
Published: (2025-06-01)

CD73 promotes the immunoregulatory functions of hepatic Tregs through enzymatic and nonenzymatic pathways in MASLD development
by: Hua Jin, et al.
Published: (2025-06-01)

CD4+/CD8+ lymphocyte ratio as a biomarker of morbidity and severity in patients with moderate and severe COVID-19
by: D. Torres-Gonzales, et al.
Published: (2025-07-01)

Expression of CD39 is associated with T cell exhaustion in ovarian cancer and its blockade reverts T cell dysfunction
by: Marius Witt, et al.
Published: (2024-12-01)

Research of subpopulation CD3+ CD4- CD8- double-negative T lymphocytes in kidney transplant recipients
by: S. V. Zybleva, et al.
Published: (2020-03-01)

ADA/CD26 axis increases intra-tumor PD-1+CD28+CD8+ T-cell fitness and affects NSCLC prognosis and response to ICB
by: Ornella Franzese, et al.
Published: (2024-12-01)

CD155 promotes the progression of colorectal cancer by restraining CD8+ T cells via the PI3K/AKT/NF-κB pathway
by: Rongpu Liang, et al.
Published: (2025-02-01)

Association of Absolute Lymphocyte Count and Circulating CD4+ and CD8+ T-Cells with Positive Clinical Outcome in Survivors of Cancer: An Observational Study
by: Suresh Rao, et al.
Published: (2019-07-01)

Development of a hydrogel-based three-dimensional (3D) glioblastoma cell lines culture as a model system for CD73 inhibitor response study
by: Marjan Bahraminasab, et al.
Published: (2024-12-01)

New insights on anti-tumor immunity of CD8+ T cells: cancer stem cells, tumor immune microenvironment and immunotherapy
by: Yibin Lin, et al.
Published: (2025-03-01)

CD8+ T cell exhaustion in the tumor microenvironment of breast cancer
by: Hanghang Xie, et al.
Published: (2024-12-01)

Exosomes derived from a mesenchymal-like endometrial regenerative cells ameliorate renal ischemia reperfusion injury through delivery of CD73
by: Bo Shao, et al.
Published: (2025-03-01)

Enhancement of Human Immunodeficiency Virus-Specific CD8<sup>+</sup> T Cell Responses with TIGIT Blockade Involves Trogocytosis
by: Nazanin Ghasemi, et al.
Published: (2024-12-01)

Analysis of frequency changes in CD8+ regulatory T cell subsets in peripheral blood of individuals with type 1 diabetes
by: Shu Chen, et al.
Published: (2024-12-01)

Deficiencies of Inducible Costimulator (ICOS) During Chronic Infection with <i>Toxoplasma gondii</i> Upregulate the CD28-Dependent Cytotoxicity of CD8<sup>+</sup> T Cells and Their Effector Function Against Tissue Cysts of the Parasite
by: Rajesh Mani, et al.
Published: (2024-12-01)

Metabolic alterations driven by LDHA in CD8 + T cells promote immune evasion and therapy resistance in NSCLC
by: Hao Wen, et al.
Published: (2025-07-01)

The progress and prospects of targeting the adenosine pathway in cancer immunotherapy
by: Yuying Yang, et al.
Published: (2025-05-01)

Immune profiling identifies CD161+CD127+CD8+ T cells as a predictive biomarker for Anti-PD-L1 therapy response in the SCLC-I subtype
by: Jingjing Qu, et al.
Published: (2025-07-01)

Two chemotherapeutic agents expand stem-like CD62L+CD8+ T cells in antitumor immune responses
by: Xiaokang Ruan, et al.
Published: (2025-04-01)

The significance of CD4+ and CD8+ T lymphocyte infiltration in esophageal squamous cell carcinoma
by: Jiang Y. Zhao, et al.
Published: (2025-01-01)

Functional characterisation of CD8+ T cells mobilised with acute supramaximal high‐intensity interval exercise: implications for immune surveillance
by: Anna Strömberg, et al.
Published: (2025-01-01)

CD3-CD8 immune score associated with a clinical score stratifies PDAC prognosis regardless of adjuvant or neoadjuvant chemotherapy
by: Coralie Schoumacher, et al.
Published: (2024-12-01)

Immunosenescence markers in T- and NK-cells according to the CD4/CD8 ratio in successfully treated people living with HIV
by: Matteo Vassallo, et al.
Published: (2025-04-01)